Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.RayBiotech has entered into a comprehensive license agreement with Emory University for access to a portfolio of antibody-related reagents and technologies.
Subscribe to our email newsletter
RayBiotech will leverage the reagents and technologies to expand its antibody-based products and services platforms.
The financial terms of the agreement were kept confidential.
Commenting on the license, RayBiotech president, COO and co-founder Rani Huang said, "Our original antibody array technology was developed by Emory researchers, and by continuing to work with Emory we have greatly expanded upon this original technology acquisition to further strengthen our portfolio of products and services."
Emory Office of Technology Transfer licensing associate Clifford Michaels said, "Adding RayBiotech to the growing number of research tool and reagent companies we work with will allow for even wider distribution and dissemination of these valuable and important tools."